CI Stock Chart & Stats
$4961.00
$0.00(0.00%)
At close: 4:00 PM EDT
$4961.00
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$4,347.50 - $6,500.00
Previous CloseN/A
Volume0.00
Average Volume (3M)116.00
Market Cap
$1.28T
Enterprise Value$104.94K
Total Cash (Recent Filing)$6.30B
Total Debt (Recent Filing)$31.88B
Price to Earnings (P/E)11.5
Beta-0.03
Next Earnings
Oct 29, 2026EPS Estimate
130.46Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)24.25
Shares Outstanding264,240,480
10 Day Avg. Volume15
30 Day Avg. Volume116
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)1.75
Price to Sales (P/S)0.27
P/FCF Ratio8.73
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$5,988.85Price Target Upside20.72% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering17
EPS Forecast (FY)527.79
Revenue Forecast (FY)$4.97T
Bulls Say, Bears Say
Bulls Say
Consistent Cash GenerationCigna's steady operating and free cash flow conversion (~0.84–0.87 of net income) is a durable strength. Reliable cash generation supports reinvestment, dividend and buyback programs, and gradual deleveraging, providing financial flexibility through business-cycle swings over the next 2-6 months and beyond.
Specialty & Care Services MomentumA 20% YoY increase in Specialty & Care Services pretax earnings reflects durable volume growth, biosimilar and specialty generic adoption, and strategic investments (Shields). Specialty pharmacy and care services are higher-margin, structurally growing areas that can sustain earnings contribution even if traditional PBM margins face pressure.
Structural Innovation: Rebate-free Model & AIThe rebate-free "Signature" model and AI-driven clinical tools represent structural changes to Cigna's PBM and care platforms. If adopted, they can shift revenue mix toward transparent fees, lower customer drug costs, and embed durable cost-management advantages that align with regulatory and market trends over the medium term.
Bears Say
PBS Earnings Pressure From TransitionPBS saw a 28% decline in pretax adjusted earnings due to client renewals and transition investments for the Signature model. This reflects a durable near-to-medium-term profitability headwind: PBM margin conversion and client timing risk may compress segment earnings until the new pricing model scales and client mixes normalize.
Margin Compression And Earnings VariabilityCigna's top-line growth masks persistent margin pressure and volatility versus earlier years. Compressed gross and operating margins reduce earnings resilience and increase sensitivity to utilization and pricing shifts, complicating medium-term forecasting and limiting durable free cash flow expansion unless margin trends stabilize.
Portfolio Exits And Strategic Reviews Reduce ScopePlanned exits (individual exchange business) and strategic reviews (eviCore) signal deliberate portfolio shaping but reduce revenue diversification and may divert management focus. These actions can limit near- to medium-term growth optionality and create one-time costs or transitional earnings impacts while strategy is executed.
Cigna News
CI FAQ
What was Cigna’s price range in the past 12 months?
Cigna lowest stock price was $4347.50 and its highest was $6500.00 in the past 12 months.
What is Cigna’s market cap?
Cigna’s market cap is $1.28T.
When is Cigna’s upcoming earnings report date?
Cigna’s upcoming earnings report date is Oct 29, 2026 which is in 86 days.
How were Cigna’s earnings last quarter?
Cigna released its earnings results on Jul 30, 2026. The company reported $134.663 earnings per share for the quarter, beating the consensus estimate of $131.478 by $3.185.
Is Cigna overvalued?
According to Wall Street analysts Cigna’s price is currently Undervalued.
Does Cigna pay dividends?
Cigna does not currently pay dividends.
What is Cigna’s EPS estimate?
Cigna’s EPS estimate is 130.46.
How many shares outstanding does Cigna have?
Cigna has 264,240,480 shares outstanding.
What happened to Cigna’s price movement after its last earnings report?
Cigna reported an EPS of $134.663 in its last earnings report, beating expectations of $131.478. Following the earnings report the stock price went up 0.685%.
Which hedge fund is a major shareholder of Cigna?
Currently, no hedge funds are holding shares in MX:CI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cigna Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$5,988.85 (20.72% Upside)
$5,988.85 (20.72% Upside)
Blogger Sentiment
Bullish
MX:CI Sentiment 75%
Sector Average 65%
Sector Average 65%
Insider Transactions
Sold Shares
Worth $4.6M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 94%
Bearish news 6%
Bearish news 6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.69%
12-Months-Change
Fundamentals
Return on Equity
2.06%
Trailing 12-Months
Asset Growth
3.90%
Trailing 12-Months
Company Description
Cigna
Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.
CI Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: consolidated revenue and EPS growth, a raised full-year EPS outlook, robust specialty and Cigna Healthcare performance, and meaningful innovation (rebate-free pharmacy model and AI-enabled savings). Primary headwinds centered on near-term PBS earnings pressure (28% decline) due to renewals and transition investments, a material special-items charge ($322M after-tax), and portfolio exits/strategic reviews that reduce near-term scope. Management presented these challenges as deliberate and manageable trade-offs to sharpen focus and accelerate long-term value creation.View all MX:CI earnings summariesCI Stock 12 Month Forecast
Average Price Target
$5,988.85
▲(20.72% Upside)